Charisis SK, Detorakis ET, Vitanova VS, Panteleontidis VA, Kounis GA, Tsilimbaris MK. Contact transcleral photodynamic cyclo-suppression in human eyes: a feasibility study.
Can J Ophthalmol 2011;
46:196-8. [PMID:
21708091 DOI:
10.3129/i10-109]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
OBJECTIVE
To evaluate the safety and efficacy of contact transcleral ciliary body photodynamic treatment (CB-PDT) with verteporfin in human eyes.
DESIGN
Prospective interventional case series.
PARTICIPANTS
Five glaucomatous blind eyes of 5 patients.
METHODS
Verteporfin (6 mg/m(2)) was infused in bolus and then the ciliary body was irradiated transclerally with a fibre optic device. Twelve spots were placed 360° and 0.5 mm behind the sclerocorneal limbus. Laser power was 80 mW and irradiation time was 3 minutes.
RESULTS
The average intraocular pressure reduction was 30% after the first month and remained below pre-treatment levels throughout a 3-month follow-up. No serious adverse events were reported.
CONCLUSIONS
CB-PDT for refractory glaucoma was safe and efficient in human eyes; larger studies are required to evaluate its possible clinical role.
Collapse